YOLFTbeta
30

Beijing Beilu Pharmaceutical

300016 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

7.82CNY-0.29 (-3.58%)

Price History

Full chart

Market Stats

Previous Close8.11
Open8.10
Day Range7.77 – 8.11
52-Week Range7.04 – 11.31
Volume24.89M
Market Cap5.56B
P/E (TTM)36.77
Forward P/E39.53
EPS0.26
Dividend Yield0.63%
Beta0.28
50-Day Avg8.58
200-Day Avg9.03

About

Beijing Beilu Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical products in China. It provides contrast agents, such as Iohexol injection, Gadolinol injection, Gadopentetate Dimeglumine injection, Iodixanol injection, and Iopamidol injection; Jiuweizhenxin granule, a central nervous system product; and oral anti-diabetic drugs, including Glimepiride tablets and Repaglinide tablets. The company was founded in 1992 and is based in Beijing, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Xu Wang
  • Employees1.19K
  • HeadquartersMaples International Office, Beijing, China, 100082, China
  • Websitehttps://www.beilu.com.cn

Leadership

  • Mr. Xu WangChairman & GM · b. 1984
  • Ms. Ni Zeng CPADeputy GM, CFO, Accounting Supervisor & Non-Independent Director · b. 1992
  • Mr. Sen LiExecutive VP & COO · b. 1981
  • Ms. Li ZongDeputy General Manager · b. 1971
  • Ms. Zehui ShaoDeputy GM, Secretary of the Board of Directors & Non-Independent Director · b. 1980
  • Ms. Xiasi KuangDeputy General Manager · b. 1982
  • Mr. Gen Chang ZhengChief Engineer & Employee Representative Member of Supervisory Board · b. 1969

Financials

Income Statement

Currency: CNY2005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue83.94M125.73M232.09M177.22M216.81M182.05M196.70M273.98M331.62M439.98M491.43M498.86M522.54M608.05M819.12M827.34M859.91M765.88M890.72M983.55M1.21B
Growth (%)-+49.78%+84.60%-23.64%+22.34%-16.03%+8.05%+39.29%+21.04%+32.68%+11.69%+1.51%+4.75%+16.37%+34.71%+1.00%+3.94%-10.93%+16.30%+10.42%+22.54%
Cost of Revenue48.17M81.50M170.62M103.08M129.17M75.35M49.85M70.62M94.99M120.25M131.13M154.52M182.97M200.69M255.26M280.52M327.99M365.47M485.37M524.59M653.18M
Gross Profit35.77M44.23M61.47M74.14M87.64M106.70M146.85M203.36M236.63M319.73M360.30M344.34M339.57M407.37M563.86M546.82M531.92M400.41M405.35M458.97M552.10M
Gross Margin42.62%35.18%26.49%41.84%40.42%58.61%74.66%74.22%71.36%72.67%73.32%69.03%64.99%67.00%68.84%66.09%61.86%52.28%45.51%46.66%45.81%
Operating Expense26.01M28.51M29.16M43.73M49.69M58.94M98.91M131.09M158.02M208.59M315.66M327.21M197.56M240.62M163.38M363.69M404.75M413.69M505.79M459.56M449.87M
Operating Income9.76M15.72M32.32M30.41M37.95M47.76M47.95M72.26M78.61M111.14M44.65M17.13M142.01M166.75M400.48M183.13M127.17M-13.28M-100.44M-595.83K102.23M
Operating Margin11.63%12.50%13.93%17.16%17.50%26.23%24.37%26.38%23.70%25.26%9.09%3.43%27.18%27.42%48.89%22.13%14.79%-1.73%-11.28%-0.06%8.48%
EBITDA10.82M21.85M38.67M35.33M45.91M54.83M59.20M72.55M93.23M126.87M71.60M43.13M157.97M184.78M417.52M221.38M230.96M109.49M33.26M147.90M245.61M
EBITDA Margin12.89%17.38%16.66%19.94%21.17%30.12%30.10%26.48%28.11%28.83%14.57%8.65%30.23%30.39%50.97%26.76%26.86%14.30%3.73%15.04%20.38%
Net Income9.14M12.29M27.67M26.05M34.86M42.77M44.21M63.04M65.97M86.77M32.58M16.38M118.82M147.76M342.44M174.70M125.51M11.28M-71.76M13.65M92.73M
Net Income Margin10.89%9.78%11.92%14.70%16.08%23.49%22.48%23.01%19.89%19.72%6.63%3.28%22.74%24.30%41.81%21.12%14.60%1.47%-8.06%1.39%7.69%
R&D-485.00K846.52K6.85M-5.31M7.66M7.97M6.75M10.68M34.88M18.79M11.42M28.07M50.68M51.72M47.23M99.01M122.33M74.45M93.39M
R&D as % of Total Revenue-0.39%0.36%3.86%-2.92%3.90%2.91%2.04%2.43%7.10%3.77%2.19%4.62%6.19%6.25%5.49%12.93%13.73%7.57%7.75%
Interest Expense864.77K1.38M916.03K217.59K186.55K6.99K14.69K20.00K6.13M232.78K3.84M750.65K40.92K66.69K131.36K6.21M45.91M49.32M53.14M58.47M39.78M
Interest Expense % of Total Revenue1.03%1.10%0.39%0.12%0.09%0.00%0.01%0.01%1.85%0.05%0.78%0.15%0.01%0.01%0.02%0.75%5.34%6.44%5.97%5.94%3.30%

Balance Sheet

Currency: CNY2005-12-312006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets107.46M125.69M141.69M159.75M451.31M475.11M524.66M583.60M620.54M907.00M1.05B956.09M1.14B1.29B1.62B2.85B2.90B2.82B2.82B2.98B3.35B
Total Liabilities42.75M54.10M51.36M26.52M17.60M7.49M33.19M59.64M61.16M240.67M117.39M54.40M71.65M82.93M173.31M955.50M818.22M892.27M1.03B1.15B930.36M
Total Equity64.07M71.17M90.13M132.94M433.68M467.63M491.47M523.96M559.38M623.20M891.16M901.69M1.07B1.21B1.45B1.74B1.86B1.78B1.65B1.67B2.26B
Cash12.07M23.63M31.29M21.38M334.35M311.42M319.14M267.28M245.56M145.28M268.42M86.27M225.47M191.04M248.40M1.01B895.02M766.73M748.45M257.46M295.44M
Total Debt20.00M18.00M20.00M5.00M-----64.18M31.90M---26.50M703.09M575.96M647.12M791.34M745.06M-
Net Debt7.93M-5.63M-11.29M-16.38M-334.35M-311.42M-319.14M-267.28M-245.56M-81.10M-236.53M-86.27M-225.47M-191.04M-221.90M-310.64M-319.07M-119.62M26.83M487.60M170.31M

Cash Flow

Currency: CNY2006-12-312007-12-312008-12-312009-12-312010-12-312011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow19.65M12.28M-4.76M57.91M37.51M45.73M22.86M41.37M42.11M80.85M76.17M144.92M175.75M156.81M176.00M108.73M127.81M58.46M163.02M156.57M
Investing Cash Flow950.96K-526.91K-896.80K-5.54M-51.61M-17.64M-44.17M-32.55M-181.72M-153.11M-203.70M-2.49M-198.12M-77.05M-151.21M-144.04M-97.76M-114.32M-580.76M-
Financing Cash Flow-9.04M-4.08M-4.25M260.60M-8.83M-20.37M-30.55M-30.55M39.34M195.40M-54.62M-3.24M-12.06M-22.39M722.59M-99.95M-153.74M53.17M-97.19M-
Capital Expenditure1.51M228.50K976.26K5.32M51.77M31.87M63.47M35.48M42.99M69.23M44.21M55.00M54.06M34.99M172.10M147.76M102.78M144.61M101.39M218.87M
Free Cash Flow18.14M12.05M-5.74M52.60M-14.26M13.85M-40.61M5.89M-878.11K11.62M31.96M89.93M121.70M121.82M3.90M-39.03M25.03M-86.15M61.63M-62.30M
Dividends Paid6.63M5.92M55.51M6.29M8.83M20.37M30.55M30.55M31.35M22.19M7.21M3.24M12.06M48.90M34.61M29.43M34.34M50.72M20.90M37.42M
FCF to OCF92.33%98.14%120.51%90.82%-38.01%30.30%-177.69%14.24%-2.09%14.37%41.96%62.05%69.24%77.69%2.22%-35.90%19.58%-147.36%37.81%-39.79%
Dividend Paid to FCF36.57%49.17%-967.58%11.97%-61.90%147.00%-75.22%518.72%-3570.41%191.00%22.57%3.60%9.91%40.14%886.99%-75.40%137.19%-58.87%33.91%-60.06%

Earnings

Report DateMar 31, 2010Sep 30, 2010Dec 31, 2010Mar 31, 2011Jun 30, 2011Sep 30, 2011Dec 31, 2011Mar 31, 2012Jun 30, 2012Nov 28, 2012Feb 27, 2013May 29, 2013Aug 28, 2013Nov 27, 2013Feb 26, 2014May 28, 2014Aug 21, 2014Oct 21, 2014Feb 11, 2015Apr 14, 2015Aug 24, 2015Oct 22, 2015Feb 29, 2016Apr 28, 2016Aug 25, 2016Oct 21, 2016Feb 27, 2017Apr 21, 2017Aug 22, 2017Oct 23, 2017Feb 27, 2018Apr 26, 2018Aug 3, 2018Oct 19, 2018Feb 27, 2019Apr 15, 2019Jul 25, 2019Oct 21, 2019Feb 26, 2020Apr 27, 2020Aug 7, 2020Oct 29, 2020Mar 18, 2021Apr 28, 2021Aug 20, 2021Oct 27, 2021Mar 29, 2022Apr 28, 2022Aug 27, 2022Oct 27, 2022Mar 29, 2023Apr 23, 2023Aug 27, 2023Oct 26, 2023Apr 22, 2024Aug 28, 2024Oct 30, 2024Apr 24, 2025Sep 2, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate----------------0.080.070.07-0.17------0.170.170.17---------------------------------
EPS Actual0.020.030.020.020.020.030.030.020.040.040.040.030.040.040.040.030.080.060.080.040.110.05-0.090.040.070.05-0.130.110.110.110.030.060.110.090.040.080.150.110.360.050.130.140.030.100.130.03-0.010.080.000.03-0.090.03-0.01-0.020.020.020.01-0.020.030.030.090.080.06
Surprise----------------0.00%-14.29%14.29%--35.29%-------35.29%-35.29%-35.29%---------------------------------
Timing----------------After-hoursPre-marketAfter-hoursAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-market----Pre-marketPre-marketAfter-hoursPre-market--Pre-market-----

Key Statistics & Ratios

Market Cap5.56B
Enterprise Value5.67B
Trailing P/E36.77
Forward P/E39.53
PEG Ratio0.00
Price / Sales4.30
Price / Book2.40
EPS0.26
Book Value4.29
Revenue (TTM)1.29B
Gross Profit (TTM)563.44M
EBITDA226.77M
Profit Margin11.01%
Operating Margin13.95%
Return on Equity6.50%
Return on Assets2.40%
Shares Outstanding581.69M
Shares Float445.84M
Beta0.28
Dividend Yield0.63%
Dividend Rate0.06
Payout Ratio23.73%

Dividends

20251×
0.05May 19, 2025
20231×
0.07May 25, 2023
20221×
0.07Apr 29, 2022
20211×
0.06Apr 19, 2021
20201×
0.07Jun 15, 2020
20191×
0.10Apr 3, 2019
20181×
0.02Apr 16, 2018
20171×
0.01Mar 31, 2017
20161×
0.01Jun 28, 2016
20151×
0.04May 25, 2015
20141×
0.07May 8, 2014
20131×
0.07Apr 16, 2013
20121×
0.07Apr 11, 2012
20111×
0.04May 19, 2011
20101×
0.02May 31, 2010

Stock Splits

  • Sep 4, 20181.5:1
  • Apr 16, 201320:10
  • May 19, 201115:10
  • May 31, 201015:10